Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-May-15 6:09 PM View:  | Saks Samuel R Chief Development Officer Director | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 67,338 | -- | -- | (100%) 67.34K to 0 | |
| 07-May-15 1:38 PM View: | Flynn James E 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 4,449,100 | -- | -- | (100%) 4.45M to 0 | |
| 06-May-15 6:07 PM View: | Stamler David A Chief Medical Officer | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 1,627 | -- | -- | (100%) 1.63K to 0 | |
| 06-May-15 6:23 PM View: | Ferguson Rodney A Director | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 2,500,590 | -- | -- | (100%) 2.5M to 0 | |
| 06-May-15 6:04 PM View: | Shah Pratik President and CEO Director | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 903,018 | -- | -- | (100%) 903.02K to 0 | |
| 06-May-15 6:07 PM View: | Chowrira Bharat M Chief Operating Officer | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 8,297 | -- | -- | (100%) 8.3K to 0 | |
| 06-May-15 6:18 PM View: | Proehl Gerald T Director | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 1,466 | -- | -- | (100%) 1.47K to 0 | |
| 07-May-15 8:56 AM View: | Thomas, McNerney & Partners... Director 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) Duplicate | 4,835,730 | -- | -- | (100%) 4.84M to 0 | |
| 06-May-15 6:03 PM View: | Zisson Alex Director 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 4,835,730 | -- | -- | (100%) 4.84M to 0 | |
| 06-May-15 6:05 PM View: | Schmid John P. Chief Financial Officer | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 144,444 | -- | -- | (100%) 144.44K to 0 | |
| 06-May-15 6:24 PM View: | Sarshar Sepehr Director | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 242,574 | -- | -- | (100%) 242.57K to 0 | |
| 06-May-15 6:35 PM View: | Greer R Scott Director | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 7,190 | -- | -- | (100%) 7.19K to 0 | |
| 06-Apr-15 5:22 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 02-Apr-15 | Exercise (in-the money or at-the-money) | 292,500 | $29.79 | $8,713,580.00 | (10%) 2.84M to 2.55M | |
| 06-Apr-15 5:22 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 02-Apr-15 | Exercise (in-the money or at-the-money) | 7,500 | $29.79 | $223,425.00 | (< 1%) 2.55M to 2.54M | |
| 17-Mar-15 5:25 PM View: | Stamler David A Chief Medical Officer | Auspex Pharmaceuticals, Inc. (ASPX) | 16-Mar-15 | Option Exercise | 3,000 | $0.90 | $2,700.00 | 305% 0.98K to 3.98K | |
| 17-Mar-15 5:25 PM View: | Stamler David A Chief Medical Officer | Auspex Pharmaceuticals, Inc. (ASPX) | 16-Mar-15 | Market Option Sale (Planned) | 3,000 | $80.00 | $240,015.00 | (75%) 3.98K to 0.98K | (2%) |
| 26-Feb-15 4:23 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 24-Feb-15 | Disposition (other) | 5,000 | -- | -- | (< 1%) 2.85M to 2.84M | |
| 26-Feb-15 4:23 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 24-Feb-15 | Disposition (other) | 195,000 | -- | -- | (6%) 3.04M to 2.85M | |
| 17-Feb-15 5:40 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 13-Feb-15 | Market Sale | 1,047 | $62.98 | $65,943.20 | (< 1%) 3.04M to 3.04M | (4%) |
| 17-Feb-15 5:40 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 13-Feb-15 | Market Sale | 40,786 | $62.98 | $2,568,820.00 | (1%) 3.08M to 3.04M | (4%) |
| 17-Feb-15 5:40 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 12-Feb-15 | Market Sale | 78,813 | $63.13 | $4,975,330.00 | (2%) 3.16M to 3.09M | (4%) |
| 17-Feb-15 5:40 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 12-Feb-15 | Market Sale | 2,021 | $63.13 | $127,582.00 | (< 1%) 3.09M to 3.08M | (4%) |
| 11-Feb-15 5:03 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 11-Feb-15 | Market Sale | 53,100 | $61.84 | $3,283,700.00 | (25%) 212.74K to 159.64K | 1% |
| 11-Feb-15 5:03 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 10-Feb-15 | Market Sale | 20,670 | $60.05 | $1,241,230.00 | (< 1%) 3.27M to 3.24M | (2%) |
| 11-Feb-15 5:03 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 10-Feb-15 | Market Sale | 530 | $60.05 | $31,826.50 | (< 1%) 3.24M to 3.24M | (2%) |
| 11-Feb-15 5:03 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 09-Feb-15 | Market Sale | 246 | $59.00 | $14,514.00 | (< 1%) 3.24M to 3.24M | (3%) |
| 11-Feb-15 5:03 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 09-Feb-15 | Market Sale | 9,608 | $59.00 | $566,872.00 | (< 1%) 3.25M to 3.24M | (3%) |
| 06-Feb-15 4:59 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 06-Feb-15 | Market Sale | 29,522 | $59.48 | $1,755,970.00 | (< 1%) 3.28M to 3.25M | (< 1%) |
| 06-Feb-15 4:59 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 06-Feb-15 | Market Sale | 757 | $59.48 | $45,026.40 | (< 1%) 3.25M to 3.25M | (< 1%) |
| 06-Feb-15 4:59 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 05-Feb-15 | Market Sale | 12,578 | $59.51 | $748,517.00 | (< 1%) 3.29M to 3.28M | (< 1%) |
| 06-Feb-15 4:59 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 05-Feb-15 | Market Sale | 322 | $59.51 | $19,162.20 | (< 1%) 3.28M to 3.28M | (< 1%) |
| 06-Feb-15 4:59 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 04-Feb-15 | Market Sale | 1,250 | $59.30 | $74,125.00 | (< 1%) 3.29M to 3.29M | (< 1%) |
| 06-Feb-15 4:59 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 04-Feb-15 | Market Sale | 48,750 | $59.30 | $2,890,880.00 | (1%) 3.34M to 3.29M | (< 1%) |
| 28-Jan-15 7:37 PM View: | Panorama Capital, L.P. 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 28-Jan-15 | Market Sale | 270,000 | $53.11 | $14,339,700.00 | (10%) 2.77M to 2.5M | (11%) |
| 30-Jan-15 2:17 PM View: | Thomas, McNerney & Partners... Director 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 28-Jan-15 | Market Sale Duplicate | 730,000 | $53.11 | $38,770,300.00 | (13%) 5.57M to 4.84M | (15%) |
| 30-Jan-15 2:15 PM View: | Zisson Alex Director | Auspex Pharmaceuticals, Inc. (ASPX) | 28-Jan-15 | Market Sale | 730,000 | $53.11 | $38,770,300.00 | (13%) 5.57M to 4.84M | (15%) |
| 28-Jan-15 1:54 PM View: | Flynn James E 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 28-Jan-15 | Market Purchase | 1,500,000 | $56.50 | $84,750,000.00 | 51% 2.95M to 4.45M | 7% |
| 28-Jan-15 6:53 PM View: | Ferguson Rodney A Director 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 28-Jan-15 | Market Sale Duplicate | 270,000 | $53.11 | $14,339,700.00 | (10%) 2.77M to 2.5M | (13%) |
| 17-Feb-15 5:39 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 08-Jan-15 | Exercise (in-the money or at-the-money) | 1,058 | $3.88 | $4,103.98 | < 1% 3.34M to 3.34M | |
| 12-Jan-15 3:56 PM View: | Zisson Alex Director | Auspex Pharmaceuticals, Inc. (ASPX) | 08-Jan-15 | Disposition | 24,008 | $51.57 | $1,238,190.00 | (< 1%) 5.59M to 5.57M | (15%) |
| 12-Jan-15 4:32 PM View: | Thomas, McNerney & Partners... Director 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 08-Jan-15 | Disposition Duplicate | 24,008 | $51.57 | $1,238,190.00 | (< 1%) 5.59M to 5.57M | (15%) |
| 12-Jan-15 4:32 PM View: | Thomas, McNerney & Partners... Director 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 08-Jan-15 | Option Exercise Duplicate | 319,135 | $3.88 | $1,237,920.00 | 6% 5.27M to 5.59M | |
| 17-Feb-15 5:39 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 08-Jan-15 | Market Sale | 3,260 | $49.13 | $160,161.00 | (< 1%) 3.34M to 3.34M | (34%) |
| 17-Feb-15 5:39 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 08-Jan-15 | Market Sale | 84 | $49.13 | $4,126.84 | (< 1%) 3.34M to 3.34M | (34%) |
| 17-Feb-15 5:39 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 08-Jan-15 | Exercise (in-the money or at-the-money) | 41,282 | $3.88 | $160,133.00 | 1% 3.3M to 3.34M | |
| 12-Jan-15 3:56 PM View: | Zisson Alex Director | Auspex Pharmaceuticals, Inc. (ASPX) | 08-Jan-15 | Option Exercise | 319,135 | $3.88 | $1,237,920.00 | 6% 5.27M to 5.59M | |
| 23-Dec-14 5:23 PM View: | Stamler David A Chief Medical Officer | Auspex Pharmaceuticals, Inc. (ASPX) | 22-Dec-14 | Market Option Sale (Planned) | 2,660 | $53.55 | $142,435.00 | (73%) 3.64K to 0.98K | (2%) |
| 23-Dec-14 5:23 PM View: | Stamler David A Chief Medical Officer | Auspex Pharmaceuticals, Inc. (ASPX) | 22-Dec-14 | Option Exercise | 2,660 | $0.90 | $2,394.00 | 271% 0.98K to 3.64K | |
| 22-Dec-14 4:45 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 18-Dec-14 | Market Sale | 190,125 | $50.14 | $9,532,870.00 | (5%) 3.5M to 3.31M | (6%) |
| 22-Dec-14 4:45 PM View: | Cmea Ventures Vii Lp 10% Owner | Auspex Pharmaceuticals, Inc. (ASPX) | 18-Dec-14 | Disposition (other) | 297,375 | -- | -- | (8%) 3.8M to 3.51M |
